Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Reexamination Certificate
2005-01-04
2005-01-04
Housel, James (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
C435S007100, C435S007920, C435S069100, C435S069300, C424S188100, C424S208100
Reexamination Certificate
active
06838236
ABSTRACT:
Pharmaceutical compositions comprising the HIV protein vpr or nucleic acid molecule encoding vpr are disclosed. Also disclosed are methods of treating patients suffering from diseases characterized by hyperproliferating undifferentiated cells such as cancer by administering such compositions. Methods of identifying compounds which have anti-HIV activity are disclosed, in particular, methods of identifying compounds which modulate the activity of vpr and of identifying compounds which inhibit vpr binding to the HIV protein gag.
REFERENCES:
patent: 4808536 (1989-02-01), Chang et al.
patent: WO 9015875 (1990-12-01), None
Harlow and Lane, 1988, Cold Spring Harbor Laboratory, New York, pp. 73 and 124.*
Luckow and Summers, 1988, Biotechnol. 6:47-55.*
Miller, 1989, BioEssays 11:91-95.*
European Patent Office Supplementary European Search Report, dated Nov. 5, 1997, 6 pages.
Hattori, N. et al., “The vpr Gene of HIV-2 is a Transactivator Necessary for viral Expression in Primary Macrophages”,Aids Res. Human Retroviruses,1991, 7(2), 177, No. XP 002031072 (Abstract only).
Levy, D.N. et al., “HIV Regulatory Gene Function Analysis in a Rhabdomyosarcoma Cell Line”,Vaccines. Modern Approaches to New Vaccines Including Prevention of Aids,Tenth Annual Meeting, Cold Spring Harbor, New York, Sep., 1992, 243-249, No. XP 000673175.
Levy, D.N. et al., “Induction of Cell Differentiation by HIV-1 VPR”,Aids Res. Human Retroviruses,1994, 10(S1), S92, No. XP 002031073 (Abstract only).
Adachi et al., “Production of Acquired Immunodeficiency Syndrome-Associated Retrovirus in Human and Nonhuman Cells Transfected with an Infectious Molecular Clone,”,J. of Virology,59:284-291, 1986.
Aguanno et al., “12-O-Tetradecanoylphorbol-13-Acetate-induced Differentiation of a Human Rhabdomyosarcoma Cell Line,”Cancer Research,50:3377-3382.
Arya et al., “Trans-Activator Gene of Human T-Lymphotropic Virus Type III (HTLV-III),”Science,229:69-73, 1985.
Chantal Petit et al., “Human Immunodeficiency Virus Infection Down-Regulates HLA Class II Expression and Induces Differentiation in Promonocytic U937 Cells,”J. Clin. Invest.79:1883-1889, 1987.
Cohen et al., “Identification of HIV-1 vpr Product and Function,”J. Acquir. Immune Defic. Syndr.3:11-18, 1990.
Cohen et al., “Human Immunodeficiency Virus vpr Product Is a Virion-Associated Regulatory Protein,”J. Virol.64:3097-3099, 1990.
Colmenares et al., “The ski Oncogene Induces Muscle Differentiation in Quail Embryo Cells,”Cell,59:293-303, 1989.
Dedera et al., “Viral Protein R of Human Immunodeficiency Virus Types 1 and 2 Is Dispensable for Replication and Cytopathogenicity in Lymphoid Cells,”J. of Virol.63:3205-3208, 1989.
Fisher et al., “A molecular clone of HTLV-III with biological activity,”Nature,316:262-265, 1985.
Gallo et al., “Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS,”Science224:500-503, 1984.
Garrett et al., “Rev Activates Expression of the Human Immunodeficiency Virus Type 1 vif and vpr Gene Products,”J. of Virology,65:1653-1657.
Gras-Masse et al., “A synthetic protein corresponding to the entire vpr gene product from the human immunodeficiency virus HIV-1 is recognized by antibodies from HIV-infected patients,”Int. J. Peptide Protein Res.,36:219-226, 1990.
Griffin et al., “Activation of HIV gene expression during monocyte differentiation by induction of NF-KB,”Nature339:70-73, 1989.
Harada et al., “Tumor Promoter, TPA, Enhances Replication of HTLV-III/LAV,”Virology,154:249-258, 1986.
Hattori et al., “The Human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages,”Proc. Natl. Acad. Sci. USA87:8080-8084, 1990.
Hiti et al., “Expression of the MyoD1 Muscle Determination Gene Defines Differentiation Capability but Not Tumorigenicity of Human Rhabdomyosarcomas,”Mol. Cell. Biol.,9:4722-4730, 1989.
Kozak, M., “Point Mutations Define a Sequence Flanking the AUG Initiator Codon That Modulates Translation by Eukaryotic Ribosomes,”Cell,44:283-292, 1986.
Levy et al., “Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDS,”Science225:840-842, 1984.
Levy et al., “Induction of Cell Differentiation by Human Immunodeficiency Virus 1 vpr,”Cell72:541-550, 1993.
Li et al., “Human Immunodeficiency Virus Type 1 DNA Synthesis, Integration, and Efficient Viral Replication in Growth-Arrested T Cells,”J. Virol.67:3969-3977, 1993.
Ling et al., “Optimization of teh Polymerase Chain Reaction with Regard to Fidelity: Modified T7, Taq, and Vent DNA Polymerases,”PCR Meth. Appl.,1:63-69, 1991.
Morgenstern et al., “Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line,”Nucl. Acids Res.,18:3587-3596, 1990.
Myers et al., “The Emergence of Simian/Human Immunodeficiency Viruses,”AIDS Res. Hum. Retrovir.,8:373-386, 1992.
Ogawa et al., “Mutational Analysis of the Human Immunodeficiency Virus vpr Open Reading Frame,”J. Virol.63:4110-4114, 1989.
Ratner et al., “Complete nucleotide sequence of the AIDS virus, HTLV-III,”Nature,313:277-284, 1985.
Ratner et al., “Complete Nucleotide Sequences of Functional Clones of the AIDS Virus,”AIDS Res. Hum. Retroviruses,3:57-69, 1987.
Reiss et al., “Antibody Response to Viral Proteins U (vpu) and R (vpr) in HIV-1-Infected Individuals,”J. of Acquired Immune Deficiency Syndromes,3:115-122, 1990.
Korber et al., “Signature Pattern Analysis: A Method for Assessing Viral Sequence Relatedness,”AIDS Res. Human Retro.,8:1549-1560, 1992.
Rich et al., “Increased Susceptibility of Differentiated Mononuclear Phagocytes to Productive Infection with Human Immunodeficiency Virus-1 (HIV-1),”J. Clin. Invest.89:176-183, 1992.
Rose et al., “Frequent Identification of HIV-1 DNa in Bronchoalveolar Lavage Cells Obtained from Individuals with the Acquired Immunodeficiency Syndrome1-3,”Am. Rev. Respir. Dis.,143:850-854, 1986.
Roulston et al., “Induction of Monocytic Differentiation and NF-kB-like Activities by Human Immunodeficiency Virus 1 Infection of Myelomonoblastic Cells,”J. Exp. Med.175:751-763, 1992.
Salahuddin et al., “Human T Lymphotropic Virus Type III Infection of Human Alveolar Macrophages,”Blood,68:281-284, 1986.
Schuitemaker et al., “Biological Phenotype of Human Immunodeficiency Virus Type 1 Clones at Different Stages of Infection: Progression of Disease Is Associated with a Shift from Monocytotropic to T-Cell-Tropic Virus Populations,”J. Virol.66:1354-1360, 1992.
Shibata et al., “Mutational Analysis of Simian Immunodeficiency Virus From African Green Monkeys and Human Immunodeficiency Virus Type 2,”J. Med. Primatol.,19:217-225, 1990.
Shibata et al., “Mutational Analysis of the Human Immunodeficiency Virus Type 2 (HIV-2) Genome in Relation to HIV-1 and Simian Immunodeficiency Virus SIVAGM,”J. Virol.64:742-747, 1990.
Siegel et al., “Morphological and biochemical differentiation of the human medulloblastoma cell line TE671,”Dev. Brain Res.,44:269-280, 1988.
Starcich et al., “Characterization of Long Terminal Repeat Sequences of HTLV-III,”Science,227:538-540, 1985.
Stratton et al., “Characterization of the human cell line TE671,”Carcinogenesis,10:899-905, 1989.
Valentin et al., “In Vitro Maturation of Mononuclear Phagocytes and Susceptibility to HIV-1 Infection,”J. of Acq. Imm. Def. Synd.,4:751-759, 1991.
Weiner et al., “Human Genes Other than CD4 Facilitate HIV-1 Infection of Murine Cells,”Pathobiology,59:361-371, 1991.
Weiner et al., “Linkage of tyro
Levy David Nathan
Refaeli Yosef
Weiner David B.
Housel James
Parkin J. S.
The Trustees of the University of Pennsylvania
The Wistar Institute
LandOfFree
VPR function and activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with VPR function and activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and VPR function and activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3386966